Received: 30 June 2020
Accepted: 6 January 2021
First Online: 21 January 2021
Ethics approval and consent to participate
: Ethical approval was obtained through the Executive Committee of the Sydney Children’s Hospitals Network Human Research Ethics Committee (HREC/16/SCHN/221).
: Not applicable.
: Dr Penny Ireland, Dr Louise Tofts and Professor Ravi Savarirayan have received fees from Biomarin Pharmaceutical for participating in advisory boards. Dr Louise Tofts is a principal investigator for the Biomarin sponsored clinical trials of Vosoritide in Achondroplasia, she does not receive any financial reimbursment for these activities.